Day: August 14, 2023

Quarterly net revenues were RMB440.3 million (US$60.7 million)1, an increase of 108.5% year-over-yearQuarterly LiDAR shipments were 52,1062 units, an increase of 946.5% year-over-year SHANGHAI, China, Aug. 14, 2023 (GLOBE NEWSWIRE) — Hesai Group (“Hesai” or the “Company”), (NASDAQ: HSAI), the global leader in three-dimensional light detection and ranging (LiDAR) solutions, today announced its unaudited financial results for the three months ended June 30, 2023. Operational Highlights  Three monthsendedJune 30, 2023   Six monthsendedJune 30, 2023ADAS LiDAR shipments 45,694   73,889Autonomous Mobility LiDAR shipments 6,412   13,051Total LiDAR shipments 52,106   86,940       Q2 2023 ADAS LiDAR shipments were 45,694 units, as compared to 1,651 units in the corresponding period of 2022. Q2 2023 Total LiDAR shipments...

WINNIPEG, Manitoba, Aug. 14, 2023 (GLOBE NEWSWIRE) — DELTA 9 CANNABIS INC. (TSX: DN) (OTC: DLTNF) (“Delta 9” or the “Company”), is pleased to announce financial and operating results for the three-month and six-month period ending June 30, 2023. Financial Highlights for the three-month period ending June 30, 2023Net revenue of $18.3 million for the second quarter of 2023, an increase of 4%, from $17.5 million for the same quarter last year.Sequential net revenue increased 8% versus $16.9 million for the three-month period ending March 31, 2023.Gross profit of $5.2 million for the second quarter of 2023, an increase of 12%, from $4.6 million for the same quarter last year. Loss from operations of $(3.5) million for the second quarter of 2023 versus a loss from operations of $(3.4) million for the same quarter last year. Adjusted...

LAS VEGAS, Aug. 14, 2023 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB: HYEX), a platform for acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals, whose proprietary and patented products target select high-growth categories within the multibillion-dollar nutraceuticals market, such as heart, brain and immune health, reported results for the three and six months ended June 30, 2023. All comparisons are to the year-ago period unless otherwise noted. Financial HighlightsNet revenue increased 25% to $588,000 in the second quarter of 2023, and up 29% to $1.2 million for the first half of the year, driven by product line and distribution channel expansion. Cost of goods sold (COGS) decreased 10% from the previous quarter to $303,000 in the second quarter of 2023. Gross margin improved to 48.4%...

CALGARY, Alberta, Aug. 14, 2023 (GLOBE NEWSWIRE) — Condor Energies Inc. (“Condor” or the “Company”) (TSX: CDR), an internationally focused energy transition company with activities in Turkiye and Kazakhstan, is pleased to announce the release of its unaudited interim condensed consolidated financial statements for the three and six months ended June 30, 2023 together with the related management’s discussion and analysis. These documents will be made available under Condor’s profile on SEDAR+ at www.sedarplus.com and on the Condor website at www.condorenergies.ca. Readers are invited to review the latest corporate presentation available on the Condor website. All financial amounts in this news release are presented in Canadian dollars, unless otherwise stated. HighlightsIn July 2023, the Government of Kazakhstan awarded Condor...

Recent Data Publications Highlight the Benefits of Oxylanthanum Carbonate (OLC) to Improve Medication Adherence and Quality of Life for Patients with Chronic Kidney Disease Feedback from FDA Expected in Fall 2023 for OLC Program UNI-494 Phase 1 Trial Progressing as Planned with IND Application Expected in 2024 LOS ALTOS, Calif., Aug. 14, 2023 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY) (the “Company” or “Unicycive”), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced its financial results for the second quarter ended June 30, 2023, and provided a business update. “Data publications and presentations continue to highlight the benefits of both our lead asset, Oxylanthanum Carbonate (OLC), and UNI-494 targeting treatment for patients with life threatening...

TORONTO, Aug. 14, 2023 (GLOBE NEWSWIRE) — ECN Capital Corp. (TSX: ECN) (“ECN Capital” or the “Company”) today reported financial results for the three-month period ended June 30, 2023. For the three-month period ended June 30, 2023, ECN Capital reported Adjusted net income applicable to common shareholders from continuing operations of $0.7 million or $0.00 per share (basic) versus $1.4 million or $0.01 per share (basic) for the previous three-month period and $11.3 million or $0.05 per share (basic) for the same period last year. “We are very excited to announce our partnership with and strategic investment by Skyline Champion (NYSE – SKY)”, said Steven Hudson, CEO of ECN Capital Corp. “With Skyline, Triad has the opportunity to partner with a premier builder and retailer in the manufactured housing space. The combination of Skyline...

BEVERLY HILLS, Calif., Aug. 14, 2023 (GLOBE NEWSWIRE) — Kartoon Studios (NYSE American:TOON) today provided a business update for the second quarter of 2023. Andy Heyward, Chairman & CEO of Kartoon Studios, stated, “While revenues grew for the 6-months ended June 30, 2023, sales for the three-month period were effected by an industry-wide slowdown of program orders by broadcasters and streaming networks, impacting our Mainframe Studios subsidiary. This slowdown was largely due to the anticipation of and the actual Writers Guild of America (WGA) and Screen Actors Guild (SAG) strikes in Hollywood, compounded by the streaming services retooling their models. This strike-driven ‘reset,’ resulted in reduced spending across the entire entertainment industry with new content orders coming to a near halt.   Although the strike is...